| P50 | author | Serena Cecchetti | Q30170385 |
| | Donatella Negri | Q42183001 |
| | Andrea Cara | Q42183004 |
| | Martina Borghi | Q56418220 |
| | Zuleika Michelini | Q56810187 |
| | Mirella Salvatore | Q57108812 |
| | Alessandra Gallinaro | Q59257018 |
| | Maria Fenicia Vescio | Q64495886 |
| | Nigel J. Temperton | Q39614751 |
| P2093 | author name string | Roberta Bona | |
| | Daniele Macchia | |
| | Andrea Canitano | |
| | Maria Rita Castrucci | |
| | Felicia Grasso | |
| | Laura Calzoletti | |
| | Laura Palladino | |
| | Valeria Morante | |
| P2860 | cites work | Altering the tropism of lentiviral vectors through pseudotyping | Q24538987 |
| | Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium | Q24671018 |
| | Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine | Q27487498 |
| | In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector | Q29547503 |
| | Influenza-associated hospitalizations in the United States | Q29619463 |
| | Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function | Q30233581 |
| | Influenza virus neuraminidase (NA): a target for antivirals and vaccines | Q30249879 |
| | Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein. | Q30351034 |
| | Cellular immune correlates of protection against symptomatic pandemic influenza. | Q30353819 |
| | Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study | Q30373419 |
| | Pseudotype-based neutralization assays for influenza: a systematic analysis. | Q30374662 |
| | A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens. | Q30377134 |
| | Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus | Q30387739 |
| | Generation and characterization of an H5N1 avian influenza virus hemagglutinin glycoprotein pseudotyped lentivirus | Q39936701 |
| | Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season | Q40070473 |
| | Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge. | Q40116170 |
| | Prolonged adherence of human immunodeficiency virus-derived vector particles to hematopoietic target cells leads to secondary transduction in vitro and in vivo | Q40221155 |
| | Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus | Q40292246 |
| | Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response | Q41661161 |
| | Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapy | Q42110927 |
| | An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera | Q42186897 |
| | Novel integrase-defective lentiviral episomal vectors for gene transfer | Q44423281 |
| | Association of serum anti-neuraminidase antibody with resistance to influenza in man. | Q44693807 |
| | Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins | Q45366363 |
| | Integrase defective, nonintegrating lentiviral vectors. | Q45857578 |
| | Estimates of deaths associated with seasonal influenza --- United States, 1976-2007 | Q50131053 |
| | Cytotoxic T-cell immunity to influenza. | Q55062679 |
| | Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells | Q57616754 |
| | Successful Immunization with a Single Injection of Non-integrating Lentiviral Vector | Q59257212 |
| | HIV-1 extrachromosomal 2-LTR circular DNA is long-lived in human macrophages | Q81600666 |
| | A simple, versatile and efficient method to genetically modify human monocyte-derived dendritic cells with HIV-1-derived lentiviral vectors | Q84261542 |
| | Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus | Q30389157 |
| | Influenza vaccine immunology | Q30398035 |
| | MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines | Q30403361 |
| | Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA). | Q33521210 |
| | Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret | Q33547457 |
| | Mucosal immunization with integrase-defective lentiviral vectors protects against influenza virus challenge in mice | Q33604567 |
| | Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination. | Q33770702 |
| | Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA | Q33785071 |
| | High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. | Q33785302 |
| | Entry kinetics and cell-cell transmission of surface-bound retroviral vector particles | Q33831103 |
| | Transduction of human antigen-presenting cells with integrase-defective lentiviral vector enables functional expansion of primed antigen-specific CD8(+) T cells | Q34085930 |
| | A nonintegrative lentiviral vector-based vaccine provides long-term sterile protection against malaria | Q34469817 |
| | Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity | Q34629133 |
| | Induction of broadly neutralising HCV antibodies in mice by integration-deficient lentiviral vector-based pseudotyped particles | Q34693362 |
| | Cell-cell transmission of VSV-G pseudotyped lentivector particles | Q34990428 |
| | A Lentiviral Vector Expressing Japanese Encephalitis Virus-like Particles Elicits Broad Neutralizing Antibody Response in Pigs | Q35799379 |
| | International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISE | Q35901999 |
| | Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines. | Q36308990 |
| | The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells | Q36349393 |
| | Analysis of the evolution and variation of the human influenza A virus nucleoprotein gene from 1933 to 1990 | Q36645539 |
| | Traditional and new influenza vaccines | Q37035833 |
| | Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model | Q37123064 |
| | Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination | Q37184801 |
| | Development and use of SIV-based Integrase defective lentiviral vector for immunization. | Q37369322 |
| | Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques | Q37499531 |
| | Integration-deficient lentiviral vectors: a slow coming of age. | Q37506025 |
| | High efficiency gene transfer to airways of mice using influenza hemagglutinin pseudotyped lentiviral vectors | Q37633995 |
| | Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes | Q37680808 |
| | Toward integrase defective lentiviral vectors for genetic immunization. | Q37721460 |
| | Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity | Q37857291 |
| | Pseudotyping Viral Vectors With Emerging Virus Envelope Proteins | Q38702981 |
| | Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate | Q38772553 |
| | Successful therapeutic vaccination with integrase defective lentiviral vector expressing nononcogenic human papillomavirus E7 protein. | Q39330979 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 171 | |
| P577 | publication date | 2018-02-05 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens | |
| P478 | volume | 9 | |